These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 20686226)
1. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits. Liu Y; Zhang HG; Jia Y; Li XH Biol Pharm Bull; 2010; 33(8):1324-30. PubMed ID: 20686226 [TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019 [TBL] [Abstract][Full Text] [Related]
3. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation. Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337 [TBL] [Abstract][Full Text] [Related]
4. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway. Fan J; Liu D; He C; Li X; He F J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662 [TBL] [Abstract][Full Text] [Related]
5. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression. Fan JS; Liu DN; Huang G; Xu ZZ; Jia Y; Zhang HG; Li XH; He FT J Ethnopharmacol; 2012 Aug; 142(3):732-8. PubMed ID: 22683903 [TBL] [Abstract][Full Text] [Related]
6. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice. Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656 [TBL] [Abstract][Full Text] [Related]
7. Effects of panax notoginseng saponin on the pathological ultrastructure and serum IL-6 and IL-8 in pulmonary fibrosis in rabbits. Zhang J; Li Q; Shao Q; Song J; Zhou B; Shu P J Cell Biochem; 2018 Nov; 119(10):8410-8418. PubMed ID: 29932250 [TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats. Du YG; Wang LP; Qian JW; Zhang KN; Chai KF Chin J Integr Med; 2016 Dec; 22(12):910-917. PubMed ID: 26712211 [TBL] [Abstract][Full Text] [Related]
9. Panax notoginseng saponins promote endothelial progenitor cell mobilization and attenuate atherosclerotic lesions in apolipoprotein E knockout mice. Liu Y; Hao F; Zhang H; Cao D; Lu X; Li X Cell Physiol Biochem; 2013; 32(4):814-26. PubMed ID: 24080960 [TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model. Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582 [TBL] [Abstract][Full Text] [Related]
11. Zhao Y; Zheng J; Yu Y; Wang L Biomed Res Int; 2018; 2018():9239354. PubMed ID: 30151392 [No Abstract] [Full Text] [Related]
12. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo. Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754 [TBL] [Abstract][Full Text] [Related]
13. 20( Liu C; Feng R; Zou J; Xia F; Wan JB Molecules; 2019 Oct; 24(20):. PubMed ID: 31623159 [TBL] [Abstract][Full Text] [Related]
14. Intervention Effects of Atorvastatin Combined with Jiang QF; Huang MY; Wu KY; Weng JL; Deng RG; Xu XJ; Xu JP; Jiang T Pharmacogn Mag; 2017; 13(51):430-438. PubMed ID: 28839368 [TBL] [Abstract][Full Text] [Related]
15. Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury. Zhu B; Zhang W; Lu Y; Hu S; Gao R; Sun Z; Chen X; Ma J; Guo S; Du S; Li P Biomed Pharmacother; 2018 Sep; 105():159-166. PubMed ID: 29857294 [TBL] [Abstract][Full Text] [Related]
16. Panax notoginseng saponins suppress lipopolysaccharide-induced barrier disruption and monocyte adhesion on bEnd.3 cells via the opposite modulation of Nrf2 antioxidant and NF-κB inflammatory pathways. Hu S; Liu T; Wu Y; Yang W; Hu S; Sun Z; Li P; Du S Phytother Res; 2019 Dec; 33(12):3163-3176. PubMed ID: 31468630 [TBL] [Abstract][Full Text] [Related]
17. UPLC/Q-TOFMS-Based Metabolomics Studies on the Protective Effect of Panax notoginseng Saponins on Alcoholic Liver Injury. Liu F; Bai X; Ding RB; Hu YJ; Su H; Wan JB Am J Chin Med; 2015; 43(4):695-714. PubMed ID: 26133752 [TBL] [Abstract][Full Text] [Related]
18. Luo H; Vong CT; Tan D; Zhang J; Yu H; Yang L; Zhang C; Luo C; Zhong Z; Wang Y Am J Chin Med; 2021; 49(4):925-939. PubMed ID: 33829964 [No Abstract] [Full Text] [Related]
19. Panax notoginseng saponins decrease cholesterol ester via up-regulating ATP-binding cassette transporter A1 in foam cells. Jia Y; Li ZY; Zhang HG; Li HB; Liu Y; Li XH J Ethnopharmacol; 2010 Oct; 132(1):297-302. PubMed ID: 20727959 [TBL] [Abstract][Full Text] [Related]
20. [Effect of Panax notoginseng saponins on cytokines in liver fibrosis rats]. Jiang H; Wang YZ; Liu XC; Xue X Zhong Yao Cai; 2013 Jul; 36(7):1123-7. PubMed ID: 24417151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]